Preprocedural C-Reactive Protein Predicts Outcomes after Primary Percutaneous Coronary Intervention in Patients with ST-elevation Myocardial Infarction a systematic meta-analysis

Figures

• 

  Figure 1. PRISMA selection flowchart47.

• 

  Figure 2. Overall and each study estimate of the RR of in-hospital all-cause mortality associated with high vs. low levels of CRP. Square boxes denote the RR, horizontal lines represent 95% confidence intervals. Weights are from random effects analysis. RR = risk ratio, CRP = C-reactive protein.

• 

  Figure 3. Overall and each study estimate of the RR of follow-up all-cause mortality associated with high vs. low levels of CRP. Square boxes denote the RR, horizontal lines represent 95% confidence intervals. Weights are from random effects analysis. RR = risk ratio, CRP = C-reactive protein.

• 

  Figure 4. Overall and each study estimate of the RR of in-hospital MACE associated with high vs. low levels of CRP. Square boxes denote the RR, horizontal lines represent 95% confidence intervals. Weights are from random effects analysis. RR = risk ratio, CRP = C-reactive protein, MACE = major adverse cardiac events.

• 

  Figure 5. Overall and each study estimate of the RR of follow-up MACE associated with high vs. low levels of CRP. Square boxes denote the RR, horizontal lines represent 95% confidence intervals. Weights are from random effects analysis. RR = risk ratio, CRP = C-reactive protein, MACE = major adverse cardiac events.

• 

  Figure 6. Overall and each study estimate of the RR of recurrent MI associated with high vs. low levels of CRP. Square boxes denote the RR, horizontal lines represent 95% confidence intervals. Weights are from random effects analysis. CRP = C-reactive protein, MI = myocardial infarction.

• 

  Figure 7. Overall and each study estimate of the RR of acute/subacute ISR associated with high vs. low levels of CRP. Square boxes denote the RR, horizontal lines represent 95% confidence intervals. Weights are from random effects analysis. RR = risk ratio, CRP = C-reactive protein, ISR = in-stent restenosis.

• 

  Figure 8. Overall and each study estimate of the RR of follow-up ISR associated with high vs. low levels of CRP. Square boxes denote the RR, horizontal lines represent 95% confidence intervals. Weights are from random effects analysis. RR = risk ratio, CRP = C-reactive protein, ISR = in-stent restenosis.

• 

  Figure 9. Overall and each study estimate of the RR of in-hospital TVR associated with high vs. low levels of CRP. Square boxes denote the RR, horizontal lines represent 95% confidence intervals. Weights are from random effects analysis. RR = risk ration, CRP = C-reactive protein, TVR = target vessel revascularization.

• 

  Figure 10. Overall and each study estimate of the RR of follow-up TVR associated with high vs. low levels of CRP. Square boxes denote the RR, horizontal lines represent 95% confidence intervals. Weights are from random effects analysis. RR = risk ratio, CRP = C-reactive protein, TVR = target vessel revascularization.

• 

  Figure 11. Funnel plot for publication bias in overall effect publication, measured as SE of log RR, against the treatment effect log RR. SE(log[RR]) = standard error of log relative risk.